Global Cloning And Mutagenesis Market Analysis 2024 – Estimated Market Size And Key Drivers

The Cloning And Mutagenesis Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Cloning And Mutagenesis Market:
https://www.thebusinessresearchcompany.com/report/cloning-and-mutagenesis-global-market-report

According to The Business Research Company’s Cloning And Mutagenesis Global Market Report 2024, The cloning and mutagenesis market size has grown exponentially in recent years. It will grow from $2.53 billion in 2023 to $3.05 billion in 2024 at a compound annual growth rate (CAGR) of 20.6%. The growth in the historic period can be attributed to advancements in genetic research, increasing demand in pharmaceutical research, rise of genetic engineering in agriculture, biomedical research applications, pioneer applications in molecular biology.

The cloning and mutagenesis market size is expected to see rapid growth in the next few years. It will grow to $6.07 billion in 2028 at a compound annual growth rate (CAGR) of 18.8%. The growth in the forecast period can be attributed to expanding applications in gene therapy, rising demand for personalized medicine, advancements in functional genomics, innovations in synthetic biology, application in agricultural biotechnology. Major trends in the forecast period include targeted gene editing in therapeutics, enhanced precision and specificity, customizable molecular tools, expanded applications in agriculture, ethical and regulatory considerations.

Rising demand for genetically modified products is expected to propel the growth of the cloning and mutagenesis market going forward. Genetically modified product refers to any organism, material, or substance that has been modified by genetic engineering techniques by deliberate manipulation of an organism’s genes to introduce new traits or characteristics. Cloning is a scientific process for producing exact genetic clones for different living species, resistant to insects and plants, and in medical sciences for gene therapy, so the rising demand for genetically modified products will support the growth of the cloning and mutagenesis market. For instance, in February 2023, according to the data imparted in the annual report published by Bayar AG, a Germany-based biotechnology and pharmaceutical company, the annual sales of crop sciences and pharmaceutical segment that includes genetically modified products, has increased significantly over 2021, where the annual sales of crop sciences segment reached to $27,794.38 million in 2022, from $22,314.79 million in 2021. Therefore, the rising demand for genetically modified products is driving the growth of the cloning and mutagenesis market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10541&type=smp

The cloning and mutagenesis market covered in this report is segmented –

1) By Product: Cloning Kits, Mutagenesis Kits, Other Product
2) By Technique: Blunt End Cloning, Topo PCR Cloning, Seamless Cloning, Site-Directed Mutagenesis, Other Techniques
3) By End User: Academic and Research Institutes, Biotechnology Companies, Other End User

Major companies operating in the cloning and mutagenesis market are developing advanced technologies such as bacteriophage genome modifying technologies to gain a competitive edge in the market. Bacteriophage genome modifying technologies refer to methods and tools used to intentionally alter the genetic material of bacteriophages, viruses that infect bacteria, for various research, therapeutic, or industrial applications. For instance, in October 2022, iNtRON Biotechnology, a South Korea-based biotechnology company, launched its 2nd generation technology for Robot Bacteriophage. This technology involves the use of random transposon mutagenesis, allowing the modification of the bacteriophage genome. This advancement, in addition to the previously developed customized CRISPR/Cas system, enables the identification and removal of non-essential genes in the bacteriophage genome. The company aims to freely design and produce bacteriophages with desired characteristics, facilitating the development of immunotherapeutic agents and antiviral solutions.

The cloning and mutagenesis market report table of contents includes:

1. Executive Summary
2.Cloning And Mutagenesis Market Characteristics
3.Cloning And Mutagenesis Market Trends And Strategies
4.Cloning And Mutagenesis Market – Macro Economic Scenario
5.Cloning And Mutagenesis Market Size And Growth
6.Cloning And Mutagenesis Segmentation
7.Cloning And Mutagenesis Regional And Country Analysis
.
.
.
27. Cloning And MutagenesisCompetitive Landscape And Company Profiles
28.Cloning And Mutagenesis Key Mergers And Acquisitions
29.Cloning And Mutagenesis Future Outlook and Potential Analysis

TOP MAJOR PLAYERS:

• Thermo Fisher Scientific
• Takara Bio Inc.
• Agilent Technologies Inc.
• Jena Bioscience GmbH
• Transgen Biotech Co
• New England Biolabs

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model